drugset / Trial / NCT02393183

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

NCT02393183 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized clinical trial is designed to evaluate the effect of selected antioxidant vitamins and minerals supplement named as ASTED: 1. β- Carotene (30 mg) 2. Vit C (100 mg) 3. Vit E (Alpha-Tocopherol Acetate): 60-200 IU 4. Calcium phosphate dihydrate (40 mg) 5. Zinc oxide (4 mg, elemental) 6. Copper gluconate (3.5 mg) 7. Sodium selenite 23 mg= Selenium 100 µg 8. Nicotinamide (a form of vit.B3) (10 mg) in patients with mild Thyroid eye disease according to EUGOGO classification. To be given twice a day.

Timeline

Start
2019-07-15
Primary completion
2022-06-15
Completion
2022-12-15

Outcome

Outcome not reported

Stopped: “Do not access to the drug”

Drugs

EvaluationDrugModalityDoseRoute
Subject ASTED Unknown — Oral